Form D · Biotechnology
Memory MD, Inc.
New York, NY · CIK 0001746749
Offering snapshot reported Sep 27, 2018 · SEC filing
- Reported sold
- $640K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Sep 4, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 27, 2018 | Initial | $640,000 | No comparison | 2 | SEC filing |
| Aug 13, 2018 | Initial | $1,387,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-322305
Convertible Promissory Notes
Sales commissions, which may include a combination of cash and warrants, have not been determined as of the filing date of this Form D
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| HRA Capital | None | Corinthian Partners, LLC · CRD 38912 |
Source: Form D, filed Sep 27, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Corrao | Executive |
| Boris Goldstein | Director, Executive, Promoter |
| Nikolay 24 Kukekov | Director, Promoter |
| Nickolay Kukekov | Director, Promoter |
| Vadim Sakharov | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
205 E. 42 Nd Street, Floor 14
New York, NY, 10017
New York, NY, 10017